DOI:
10.1039/C5RA02530C
(Paper)
RSC Adv., 2015,
5, 33579-33585
Self-assembly of two high-nuclearity manganese calixarene-phosphonate clusters: diamond-like Mn16 and drum-like Mn14†
Received
9th February 2015
, Accepted 31st March 2015
First published on 31st March 2015
Abstract
Two novel high-nuclearity manganese clusters, [Mn14(BSC4A)3(tBuPO3)6(μ4-OH)3Cl(H2O)(CH3OH)]·1.5CH3OH (1) and [Mn16(BSC4A)3(PhPO3)7(HPO4)(μ4-OH)3Cl(H2O)(CH3OH)4]·4.5CH3OH (2) (H4BSC4A = p-tert-butylsulfonylcalix[4]arene; tBuPO3H2 = tert-butylphosphonic acid; PhPO3H2 = phenylphosphonic acid) have been solvothermally obtained and structurally characterized. Crystal structural analyses reveal that the phosphonate ligands have a large influence on the structures of the polynuclear manganese clusters: complex 1 possesses a drum-like MnII14 core, which is constructed from three Mn4–BSC4A molecular building blocks (MBBs) and six tBuPO32− ligands and capped by two MnII ions; while complex 2 has a diamond-like MnII16 core, which also consists of three Mn4–BSC4A MBBs, but connected by seven PhPO32− linkers and a tetrahedral Mn4 cluster housing a phosphate anion generated in situ. To the best of our knowledge, complex 2 gives the first calixarene-based cluster linked by both organic phosphonate and inorganic phosphate ligands, and also presents the highest nuclearity manganese complex with the H4BSC4A ligand to date. Magnetic measurements suggest the presence of antiferromagnetic interactions between the adjacent MnII spin carriers for both complexes.
Introduction
The exploration of polynuclear transition metal clusters is currently a fertile topic of research, not only because of their architectural beauty1 but also because of their immense technological applications in molecular magnets,2 catalysts,3 optics4 and so on.5 Numerous transition metal clusters with different nuclearities, distinct geometries and interesting properties have been obtained utilizing multidentate ligands through hydro(solvo)thermal conditions, which may lead to some unexpected architectures induced by in situ generated ligands.6 p-tert-Butylsulfonylcalix[4]arene (H4BSC4A, Scheme 1), a calixarene derivative possessing four lower-rim phenolic oxygen atoms and eight sulfonyl oxygen atoms, could be an ideal choice for the construction of polymetallic compounds.7 Moreover, it has been found that one H4BSC4A molecule tends to coordinate to three or four divalent transition metal (TM) ions to form a shuttlecock-like TM3/4–BSC4A molecular building block (MBB), which can be further bridged by different linkers into polynuclear entities. For example, two novel barrel-shaped Co16 containers built from four Co4–BSC4A MBBs and eight dicarboxylate ligands,8 a novel nest-like C4-symmetric Co24 metallamacrocycle constructed by eight Co3–BSC4A molecular building blocks (MBBs) and six 1,2,4-triazolate ligands,9 several octahedral M24 nanocages (M = Co, Ni) with six M4–BSC4A MBBs and twelve dicarboxylates or eight tricarboxylates have been reported in recent years.10 In addition, its analogs p-tert-butylcalix[4]arene (H4BC4A) and p-tert-butylthiacalix[4]arene (H4BTC4A) have also been widely utilized in the syntheses of polymetallic compounds.11
 |
| Scheme 1 p-tert-Butylsulfonylcalix[4]arene (H4BSC4A). | |
On the other hand, phosphonate ligands possess different anionic forms and can adopt various coordination modes to bind to different metal ions.12 In the past few years, a number of groups have been utilizing phosphonate ligands with preformed cages/clusters or pyrazoles, 2-chloro-6-hydroxypyridine, antimonite and carboxylate as co-ligands to make new polymetallic complexes.13
Our group has been focused on preparing new calixarene-based polynuclear compounds with fascinating structures and interesting physical properties.14 In our recent work, we have isolated some calix[4]arene-based high-nuclearity complexes with interesting architectures and properties by the introduction of phosphonate/phosphate as co-ligands. For example, we have synthesized eight thiacalix[4]arene-based high-nuclearity TM4n nanocages (TM = Co, Ni; n = 2–6) constructed by bridging TM4–calix[4]arene MBBs with phosphate/phosphonate ligands,15 two large alkali-metal templated Na2Co24 and KCo24 clusters constructed from six TM4–thiacalix[4]arene MBBs and six phosphate linkers,16 and a tri-capped trigonal prismatic Co9 clusters with spin-glass behavior based on calix[4]arene and phosphonate ligands.17 As an extension of our work, we have tried to expand the mixed calix[4]arene-phosphonate system using other transition metal salts. Fortunately, we have successfully obtained two new calix[4]arene-based manganese(II) clusters having the general molecular formula of [MnII14(BSC4A)3(tBuPO3)6(μ4-OH)3Cl(H2O)(CH3OH)]·1.5CH3OH (1) and [MnII16(BSC4A)3(PhPO3)7(HPO4)(μ4-OH)3Cl(H2O)(CH3OH)4]·4.5CH3OH (2) (tBuPO3H2 = tert-butylphosphonic acid; PhPO3H2 = phenylphosphonic acid). Single-crystal X-ray diffraction analyses reveal that the phosphonate ligands have a significant influence on the structure of the polynuclear manganese(II) compounds. Although both complexes contain three Mn4–BSC4A molecular building blocks MBBs (Fig. 1), they are bridged by different numbers of manganese cations, different kinds and numbers of phosphonate ligands as well as other auxiliary ligands. In fact, the structure of 1 possesses a drum-like MnII14 core, whereas 2 a diamond-like MnII16 core. Bond distances, bond valence sum (BVS) calculations and charge balance authenticate that all manganese centers in both complexes are at +2 oxidation states.18 To the best of our knowledge, there are only three tetranuclear Mn4 clusters based on H4BSC4A in the literature, thus 2 presents the highest nuclearity manganese complex with H4BSC4A ligand so far.19 In this work, the syntheses, crystal structures and magnetic properties of complexes 1 and 2 were studied.
 |
| Fig. 1 Shuttlecock-like MBB of Mn4–BSC4A, whose base is capped by a μ4-hydroxide anion. | |
Experimental section
General remarks
The H4BSC4A ligand was synthesized as previously reported.20 All manipulations were performed under aerobic conditions utilizing chemical materials purchased from commercial sources and without further purification. The (C, H, N) elemental analyses were performed using a German Elementary Varil EL III instrument. Thermogravimetric analysis (TGA) curves were carried out on a NETZSCH STA 449C thermal analyzer in the temperature range of 25–900 °C in a nitrogen stream with a heating rate of 10 °C min−1. The powder X-ray diffraction (PXRD) data were collected by a RIGAKU-DMAX2500 X-ray diffractometer using Cu Kα radiation (λ = 0.154 nm) at room temperature. Magnetic susceptibility measurements were measured with a Quantum Design PPMS-9T and MPMS-XL magnetometer. The experimental magnetic data were corrected for the diamagnetism of the constituent atoms (Pascal's tables).
Synthesis of complex 1
A mixture of H4BSC4A (0.1 mmol, 85 mg), MnCl2·4H2O (0.4 mmol, 80 mg), tBuPO3H2 (0.1 mmol, 14 mg) and 10 mL CH3OH was sealed in a 25 mL Teflon-lined bomb at 130 °C for 72 h. Eventually, the mixture was cooled down slowly to room temperature for 24 h, after which colorless block-shaped crystals of 1 were isolated by filtration, washed with CH3OH and air dried (58% yield based on H4BSC4A ligand). Elemental analysis (%) for C145H177O59P6S12ClMn14: calcd: C, 41.08; H, 4.20; found (after dried in vacuum): C, 40.66; H, 4.13. The phase purity of the sample was determined by PXRD (Fig. S3, in the ESI†).
Synthesis of complex 2
Complex 2 was obtained in a procedure similar to that of 1, except that PhPO3H2 (0.1 mmol, 16 mg) was used instead of tBuPO3H2 (0.1 mmol, 14 mg). Yield 76% based on H4BSC4A ligand. Elemental analysis (%) for C166H189O69 P8S12ClMn16: calcd: C, 41.23; H, 3.94; found (after dried in vacuum): C, 42.06; H, 3.87. The phase purity of the sample was determined by PXRD (Fig. S4, in the ESI†).
X-ray crystallography
Data collection for 1 was performed on a SuperNova diffractometer at 100 K with graphite-monochromated Mo-Kα (λ = 0.71073 Å), while data of 2 was collected using a Rigaku Saturn 70 CCD diffractometer at 293 K with graphite-monochromated Mo-Kα (λ = 0.71073 Å). Crystallographic data and structure refinement for compounds 1 and 2 were summarized in Table 1. Data were corrected for absorption using the CrystalClear program.21 Structure solution by direct methods and full-matrix least-squares refinement on F2 were solved by using SHELXTL-97 program package.22 All the non-hydrogen atoms were refined anisotropically except some badly disordered carbon atoms of tert-butyl groups. Organic hydrogen atoms of the ligands were placed in calculated positions and refined isotropically with fixed thermal factors. Moreover, diffuse electron density together with highly disordered MeOH molecules of crystallization could not be generated and were not included for both structures, thus the crystal structures were treated by the “SQUEEZE” method, a part of the PLATON package of crystallographic software.23 This had dramatically improved the agreement indices. Moreover, the high R1 and wR2 factor for both title complexes might be due to the weak crystal diffractions and the disorder of the tert-butyl groups. Crystallographic details for both compounds are available in the ESI† in CIF format.
Table 1 Crystallographic data and structure refinement for complexes 1 and 2
Complex |
1 |
2 |
R1 = ∑‖Fo| − |Fc‖/∑|Fo|. wR2 = {∑[w(Fo2 − Fc2)2]/∑[w(Fo2)2]}1/2. |
Formula |
C145H177O59P6 |
C166H189O69P8 |
|
S12ClMn14 |
S12ClMn16 |
M/g mol−1 |
1.4225 |
1.4528 |
T/K |
100 |
293 |
Crystal system |
Monoclinic |
Orthorhombic |
Space group |
P21/c |
Pnma |
a/Å |
18.7857(3) |
34.378(4) |
b/Å |
39.0027(6) |
28.140(4) |
c/Å |
27.3636(4) |
22.849(3) |
α (°) |
90.00 |
90 |
β (°) |
99.2080(10) |
90 |
γ (°) |
90.00 |
90 |
V/Å3 |
19790.8(5) |
22 104(5) |
Z |
4 |
4 |
μ (mm−1) |
1.122 |
1.139 |
Data measured |
101 744 |
144 413 |
Ind. reflns |
34 809 |
20 856 |
Parameters |
2183 |
1313 |
GOF on F2 |
1.050 |
1.086 |
R1a [I > 2σ(I)] |
0.0561 |
0.0709 |
wR2b |
0.1335 |
0.1987 |
CCDC number |
1046923 |
1046924 |
Results and discussion
Crystal structures
Solvothermal treatment of H4BSC4A with tBuPO3H in methanol solution affords colorless single crystals of 1. X-ray data diffraction analysis reveals that complex 1 crystallizes in the monoclinic system with space group P21/c and has a tetradecanuclear MnII14 cluster. As can be seen from Fig. 2, there are three fully deprotonated BSC4A4− ligands, each of which coordinates to four MnII ions by its lower-rim phenoxy oxygen and bridge sulfur oxygen atoms forming a shuttlecock-like Mn4–BSC4A MBB, whose bottom is capped by one μ4-hydroxide anion. The bottoms of the Mn4–BSC4A MBBs are linked together through the oxygen atoms from six different tBuPO32− ligands to form the body of a drum, whose “upper” and “lower” faces are each further capped by a MnII ion (Fig. 3). These 14 crystallographically independent MnII ions can be divided into three groups according to their coordination environments: (i) 12 Mn ions (Mn1–Mn12) from the abovementioned three Mn4−BSC4A MBBs are coordinated by two phenoxo oxygen atoms along with one sulfonyl oxygen atom originating from one BSC4A4− ligands, one μ4-hydroxide anion, and two oxygen atoms from two independent tBuPO32− ligands to form a six-coordinated distort octahedral geometries; (ii) Mn13 is bounded by five oxygen atoms deriving from three different tBuPO32− ligands, one water oxygen and one chlorine to form a seven-coordinated pentagonal bipyramid geometry; (iii) while the rest Mn14 ion is coordinated by four oxygen atoms from three independent tBuPO32− ligands and one ligated MeOH molecule to form a five-coordinated square-pyramid geometry. Impressively, six tBuPO32− ligands coordinate to the Mn ions in two different chelating modes: three with [5.212234245] coordination mode, and the rest three with [5.221] fashion according to Harris notation (Scheme 2).24 To the best of our knowledge, there are two compounds supported by H4BSC4A ligands with tetradecanuclear structures. One is constructed from two Co4–BSC4A building blocks, two Co3–BSC4A subunits and 12 bridging tetrazolate ligands,7d and the other one is a cationic cluster composed of three BSC4A4− ligands and 14 CoII ions and formed by two superposed planar, bodycentered, hexagonal cores by seven CoII ions.7e However, they are different from complex 1 which possesses a drum-shaped MnII14 core.
 |
| Fig. 2 Molecular structure of complex 1. The hydrogen atoms and isolated solvent molecules are omitted for clarity. | |
 |
| Fig. 3 Core structure of complex 1. Calix[4]arene ligands and tBu groups are omitted for clarity. | |
 |
| Scheme 2 Observed bonding modes of the phosphonate and phosphate ligands. | |
The phosphonate ligands have a pivotal influence on the final structure of title complexes. By replacing the tBuPO3H ligand to PhPO3H ligand in the similar reaction, complex 2 was obtained. It crystallizes in an orthorhombic cell with the space group Pnma, and contains an unprecedented diamond-like MnII16 core. As shown in Fig. 4a, complex 2 is also constructed from three Mn4−BSC4A MBBs to compare with 1, but linked by seven PhPO32− ligands and one phosphate-based tetrahedral Mn4 cluster. The “upper” part of the core is built by three Mn4–BSC4A MBBs and linked together through four different PhPO32− ligands, while the “lower” part is a tetrahedral Mn4 cluster, which are bridged by three different PhPO32− ligands and one in situ generated HPO42− anion (Fig. 5). Then the “upper” part and “lower” part are further linked by three different PhPO32− ligands to form a diamond-like MnII16 core. Unlike 1, complex 2 has a crystallographic symmetry plane, so its asymmetric unit includes half of the formula and there are nine crystallographically independent manganese atoms (Mn1–Mn9) in this structure. Six Mn ions (Mn1–Mn6) from the Mn4−BSC4A MBBs have the same coordination environments to compare with those of 1. The remaining three Mn ions are all six-coordinated and exhibit octahedral geometries, but they have different coordination environments. Specially, Mn7 is in O6 environment with four oxygen atoms from two different PhPO32− ligands, one oxygen from HPO42− anion and one water oxygen; Mn8 is in ClO5 environment with two oxygen atoms from two different PhPO32− ligands, one oxygen from HPO42− anion, one chlorine anion and two MeOH molecules; Mn9 is in O6 environment with four oxygen atoms from three different PhPO32− ligands, one oxygen from HPO42− anion and one MeOH molecules (Fig. 4b). Notably, seven PhPO32− anions adopt four different binding modes: (i) three ligands coordinate in a [6.222] manner; (ii) two adopt the [5.221] modes; (ii) one binds in a [5.212234245] fashion; (iv) while the remaining one coordinates in a [4.211] mode. It should be note that the difference between the final structures of title complexes might arise from the unexpected in situ generated HPO42− anion. The HPO42− anion in this structure is generated from in situ reactions of PhPO3H2 molecule during the solvothermal conditions, which coordinates to four Mn centers in a [4.1111] coordination mode (Scheme 2) to form a tetrahedral Mn4 cluster and further to generate unexpected cluster structure. We note that this phosphate anion carries a hydrogen atom, because one of the distances between the phosphorus and oxygen atoms are considerably longer than the other three, which is in agreement with the previously reported phosphate-based compounds.25 To the best of our knowledge, complex 2 gives the first calixarene-based cluster linked by both organic phosphonate and inorganic phosphate ligands. This sheds some light into the design and construction of other calixarene-based high-nuclearity compounds by utilizing both phosphonate and phosphate linkers. Although there have been several reports on calix[4]arene-based M16 (M = Co, Ni) clusters, those clusters are squares constructed by four Co4–calix[4]arene MBBs with eight in situ generated 5-methyltetrazolates or rigid 1,3-benzenedicarboxylates, this unusual diamond-like Mn16 architecture has not been reported heretofore.10
 |
| Fig. 4 (a) Molecular structure of complex 2. (b) X-ray asymmetric unit of 2. The hydrogen atoms and isolated solvent molecules are omitted for clarity. | |
 |
| Fig. 5 Core structure of complex 2. Calix[4]arene ligands and phenyl groups are omitted for clarity. Symmetry code: A x, 3/2-y, z. | |
Magnetic studies
The variable-temperature dependence of solid state direct current (dc) magnetic susceptibilities were collected on the polycrystalline samples of 1 and 2 in the temperature range of 2–300 K under a field of 1 kOe. These results are plotted as the χmT products (χm is molar magnetic susceptibility) versus temperature in Fig. 6 and 7. The χmT values at 300 K are 48.92 and 54.81 cm3 K mol−1 for 1 and 2, which are smaller than the expected values of 61.25 and 70 cm3 K mol−1 for 14 and 16 non-interacting high-spin MnII spin carrier (S = 5/2, g = 2), respectively.26 As the temperature is decreased, the χmT values continuously decrease to 2.07 and 5.06 cm3 K mol−1 until the lowest temperature 2 K for 1 and 2, respectively. The χm−1 data above 50 K obey the Curie–Weiss Law with Curie constants (C) = 62.38 and 70.37 and Weiss constants (θ) = −83.72 and −85.96 cm3 K mol−1 for 1 and 2, respectively. The negative Weiss constants, together with the trend of χmT vs. T plots, reveal the presence of strong antiferromagnetic interaction between MnII ions. However, the coupling parameters (J) of both title clusters cannot be carried out owing to the complexities of the structures.
 |
| Fig. 6 Temperature dependence of χmT measured in a 1 kOe field. The solid lines are the best fitting to the Curie–Weiss Law. Magnetization curves (inset graphs) measured at 2−7 K for 1. | |
 |
| Fig. 7 Temperature dependence of χmT measured in a 1 kOe field. The solid lines are the best fitting to the Curie–Weiss Law. Magnetization curves (inset graphs) measured at 2−7 K for 2. | |
The field dependence of magnetization (M) versus field (H) data for 1 and 2 from 2 to 7 K are investigated with the applied magnetic field H in the range 0–80 kOe (inset of Fig. 6 and 7, respectively). The magnetization of 1 and 2 continuously increases almost linearly and the magnetization value at the highest field (80 kOe and 2 K) is 12.24 and 12.95 Nβ for complexes 1 and 2 respectively, which are far from the saturation sum values of 14 and 16 MnII ions. The temperature-dependent alternating current (ac) susceptibility studies of 2 are also carried out between 20 and 2 K with and without applied dc field, but no peaks for the out-of-phase component is observed (Fig. S1, in the ESI†). Moreover, no obvious hysteresis loop is observed for 2 at 2 K (Fig. S2, in the ESI†). All these results reveal neither long-range ordering nor single-molecule magnet behavior above 2 K for 2.
Conclusion
In conclusion, we have synthesized two novel polynuclear manganese clusters based on H4BSC4A and phosphonate ligands. We found that the phosphonate ligands have an important influence on the final structures of title complexes. When tBuPO3H2 was utilized, a tetradecanuclear drum-like MnII14 cluster (1) was obtained. By variation of the phosphonic acid from tBuPO3H2 to PhPO3H2, a hexadecanuclear diamond-like MnII16 cluster (2) was synthesized. To the best of our knowledge, complex 2 presents the highest nuclearity manganese complex supported by H4BSC4A ligand and also gives the first calixarene-based cluster linked by both organic phosphonate and inorganic phosphate ligands. Magnetic measurements suggest the presence of antiferromagnetic interactions between the adjacent MnII centers. Our future studies will focus on polynuclear lanthanide compounds of mixed calixarene-phosphonate ligands.
Acknowledgements
We thank 973 Program (2011CB932504), National Natural Foundation of China (21131006) and the Natural Science Foundation of Fujian Province.
Notes and references
-
(a) P. Albores and E. Rentschler, Angew. Chem., Int. Ed., 2009, 48, 9366 CrossRef CAS PubMed;
(b) G. E. Kostakis, S. P. Perlepes, V. A. Blatov, D. M. Proserpio and A. K. Powell, Coord. Chem. Rev., 2012, 256, 1246 CrossRef CAS PubMed;
(c) E.-B. Wang, J. Am. Chem. Soc., 2009 Search PubMed;
(d) Y. Q. Hu, M. H. Zeng, K. Zhang, S. Hu, F. F. Zhou and M. Kurmoo, J. Am. Chem. Soc., 2013, 135, 7901 CrossRef CAS PubMed;
(e) Y. Shichibu, M. Zhang, Y. Kamei and K. Konishi, J. Am. Chem. Soc., 2014, 136, 12892 CrossRef CAS PubMed.
-
(a) A. J. Tasiopoulos, A. Vinslava, W. Wernsdorfer, K. A. Abboud and G. Christou, Angew. Chem., Int. Ed. Engl., 2004, 43, 2117 CrossRef CAS PubMed;
(b) S. Sanz, J. M. Frost, M. B. Pitak, S. J. Coles, S. Piligkos, P. J. Lusby and E. K. Brechin, Chem. Commun., 2014, 50, 3310 RSC;
(c) Y. M. Li, H. J. Lun, C. Y. Xiao, Y. Q. Xu, L. Wu, J. H. Yang, J. Y. Niu and S. C. Xiang, Chem. Commun., 2014, 50, 8558 RSC;
(d) H.-L. Wu, Z.-M. Zhang, Y.-G. Li and E.-B. Wang, RSC Adv., 2014, 4, 43806 RSC.
-
(a) G. Wang, B. Huang, X. Ma, Z. Wang, X. Qin, X. Zhang, Y. Dai and M.-H. Whangbo, Angew. Chem., Int. Ed., 2013, 52, 4810 CrossRef CAS PubMed;
(b) A. Alzamly, S. Gambarotta, I. Korobkov, M. Murugesu, J. J. H. Le Roy and P. H. M. Budzelaar, Inorg. Chem., 2014, 53, 6073 CrossRef CAS PubMed;
(c) X. You, Z. Wei, H. Wang, D. Li, J. Liu, B. Xu and X. Liu, RSC Adv., 2014, 4, 61790 RSC;
(d) P. Kumar, S. Kumar, S. Cordier, S. Paofai, R. Boukherroub and S. L. Jain, RSC Adv., 2014, 4, 10420 RSC.
-
(a) R. Peng, M. Li and D. Li, Coord. Chem. Rev., 2010, 254, 1 CrossRef CAS PubMed;
(b) L. Chen, F. L. Jiang, Z. Z. Lin, Y. F. Zhou, C. Y. Yue and M. C. Hong, J. Am. Chem. Soc., 2005, 127, 8588 CrossRef CAS PubMed;
(c) M. Knorr, A. Khatyr, A. Dini Aleo, A. El Yaagoubi, C. Strohmann, M. M. Kubicki, Y. Rousselin, S. M. Aly, D. Fortin, A. Lapprand and P. D. Harvey, Cryst. Growth Des., 2014, 14, 5373 CrossRef CAS;
(d) P. Roesch, J. Nitsch, M. Lutz, J. Wiecko, A. Steffen and C. Müller, Inorg. Chem., 2014, 53, 9855 CrossRef CAS PubMed.
-
(a) A. J. Edwards, R. S. Dhayal, P.-K. Liao, J.-H. Liao, M.-H. Chiang, R. O. Piltz, S. Kahlal, J.-Y. Saillard and C. W. Liu, Angew. Chem., Int. Ed., 2014, 53, 7214 CrossRef CAS PubMed;
(b) J. Park, L.-B. Sun, Y.-P. Chen, Z. Perry and H.-C. Zhou, Angew. Chem., Int. Ed., 2014, 53, 5842 CrossRef CAS PubMed;
(c) N. Barrabés, B. Zhang and T. Bürgi, J. Am. Chem. Soc., 2014, 136, 14361 CrossRef PubMed;
(d) D. Zhang, Z. Liang, S. Xie, P. Ma, C. Zhang, J. Wang and J. Niu, Inorg. Chem., 2014, 53, 9917 CrossRef CAS PubMed;
(e) S. Khatua, S. Goswami, S. Parshamoni, H. S. Jena and S. Konar, RSC Adv., 2013, 3, 25237 RSC.
-
(a) Q. H. Chen, F. L. Jiang, L. Chen, M. Yang and M. C. Hong, Chem.–Eur. J., 2012, 18, 9117 CrossRef CAS PubMed;
(b) S. W. Bi Yanfeng, M. Liu, S. Du and W. Liao, Chem. Commun., 2013, 49, 6785 RSC;
(c) Y. F. Bi, W. P. Liao, G. C. Xu, R. P. Deng, M. Y. Wang, Z. J. Wu, S. Gao and H. J. Zhang, Inorg. Chem., 2010, 49, 7735 CrossRef CAS PubMed.
-
(a) T. Kajiwara, H. S. Wu, T. Ito, N. Iki and S. Miyano, Angew. Chem., Int. Ed., 2004, 43, 1832 CrossRef CAS PubMed;
(b) T. Kajiwara, N. Iki and M. Yamashita, Coord. Chem. Rev., 2007, 251, 1734 CrossRef CAS PubMed;
(c) C. Redshaw, M. R. J. Elsegood, J. A. Wright, H. Baillie-Johnson, T. Yamato, S. De Giovanni and A. Mueller, Chem. Commun., 2012, 48, 1129 RSC;
(d) C. M. Liu, D. Q. Zhang, X. Hao and D. B. Zhu, Eur. J. Inorg. Chem., 2012, 4210 CrossRef;
(e) M. Lamouchi, E. Jeanneau, G. Novitchi, D. Luneau, A. Brioude and C. Desroches, Inorg. Chem., 2013, 53, 63 CrossRef PubMed . CCDC number for reference 7e are 873249, 873255 and 881987.
- F.-R. Dai and Z. Wang, Chem. Commun., 2014, 50, 5385 RSC.
- C.-M. Liu, D.-Q. Zhang, X. Hao and D.-B. Zhu, Chem.–Eur. J., 2011, 17, 12285 CrossRef CAS PubMed.
-
(a) F.-R. Dai and Z. Wang, J. Am. Chem. Soc., 2012, 134, 8002 CrossRef CAS PubMed;
(b) F. R. Dai, U. Sambasivam, A. J. Hammerstrom and Z. Wang, J. Am. Chem. Soc., 2014, 136, 7480 CrossRef CAS PubMed.
-
(a) M. Liu, W. Liao, C. Hu, S. Du and H. Zhang, Angew. Chem., Int. Ed., 2012, 51, 1585 CrossRef CAS PubMed;
(b) Y. F. Bi, S. C. Du and W. P. Liao, Coord. Chem. Rev., 2014, 276, 61 CrossRef CAS PubMed;
(c) H. Tan, S. Du, Y. Bi and W. Liao, Inorg. Chem., 2014, 53, 7083 CrossRef CAS PubMed;
(d) G. Karotsis, S. Kennedy, S. J. Teat, C. M. Beavers, D. A. Fowler, J. J. Morales, M. Evangelisti, S. J. Dalgarno and E. K. Brechin, J. Am. Chem. Soc., 2010, 132, 12983 CrossRef CAS PubMed;
(e) S. M. Taylor, R. D. McIntosh, S. Piligkos, S. J. Dalgarno and E. K. Brechin, Chem. Commun., 2012, 48, 11190 RSC;
(f) S. M. Taylor, J. M. Frost, R. McLellan, R. D. McIntosh, E. K. Brechin and S. J. Dalgarno, CrystEngComm, 2014, 16, 8098 RSC.
-
(a) Y.-Z. Zheng, M. Evangelisti and R. E. P. Winpenny, Angew. Chem., Int. Ed., 2011, 50, 3692 CrossRef CAS PubMed;
(b) Y. Z. Zheng, E. M. Pineda, M. Helliwell and R. E. P. Winpenny, Chem.–Eur. J., 2012, 18, 4161 CrossRef CAS PubMed;
(c) Y.-Z. Zheng, M. Evangelisti, F. Tuna and R. E. P. Winpenny, J. Am. Chem. Soc., 2012, 134, 1057 CrossRef CAS PubMed;
(d) J. A. Sheikh, A. Adhikary, H. S. Jena, S. Biswas and S. Konar, Inorg. Chem., 2014, 53, 1606 CrossRef CAS PubMed.
-
(a) S. Khanra, S. Konar, A. Clearfield, M. Helliwell, E. J. L. McInnes, E. Tolis, F. Tuna and R. E. P. Winpenny, Inorg. Chem., 2009, 48, 5338 CrossRef CAS PubMed;
(b) S. Ali, C. A. Muryn, F. Tuna and R. E. P. Winpenny, Dalton Trans., 2010, 39, 124 RSC;
(c) J. A. Sheikh, H. S. Jena, A. Adhikary, S. Khatua and S. Konar, Inorg. Chem., 2013, 52, 9717 CrossRef CAS PubMed;
(d) S. K. Langley, M. Helliwell, S. J. Teat and R. E. Winpenny, Inorg. Chem., 2014, 53, 1128 CrossRef CAS PubMed;
(e) S. Khanra, M. Helliwell, F. Tuna, E. J. L. McInnes and R. E. P. Winpenny, Dalton Trans., 2009, 6166 RSC.
-
(a) K. Xiong, F. Jiang, Y. Gai, Z. He, D. Yuan, L. Chen, K. Su and M. Hong, Cryst. Growth Des., 2012, 12, 3335 CrossRef CAS;
(b) K. Xiong, F. Jiang, Y. Gai, D. Yuan, L. Chen, M. Wu, K. Su and M. Hong, Chem. Sci., 2012, 3, 2321 RSC;
(c) K. Xiong, X. Wang, F. Jiang, Y. Gai, W. Xu, K. Su, X. Li, D. Yuan and M. Hong, Chem. Commun., 2012, 48, 7456 RSC;
(d) K. C. Xiong, F. L. Jiang, Y. L. Gai, D. Q. Yuan, D. Han, J. Ma, S. Q. Zhang and M. C. Hong, Chem.–Eur. J., 2012, 18, 5536 CrossRef CAS PubMed;
(e) K. Su, F. Jiang, J. Qian, M. Wu, K. Xiong, Y. Gai and M. Hong, Inorg. Chem., 2013, 52, 3780 CrossRef CAS PubMed;
(f) K. Xiong, F. Jiang, Y. Gai, Y. Zhou, D. Yuan, K. Su, X. Wang and M. Hong, Inorg. Chem., 2012, 51, 3283 CrossRef CAS PubMed.
-
(a) K. Su, F. Jiang, J. Qian, Y. Gai, M. Wu, S. M. Bawaked, M. Mokhtar, S. A. Al-Thabaiti and M. Hong, Cryst. Growth Des., 2014, 14, 3116 CrossRef CAS;
(b) K. Su, F. Jiang, J. Qian, M. Wu, Y. Gai, J. Pan, D. Yuan and M. Hong, Inorg. Chem., 2014, 53, 18 CrossRef CAS PubMed.
- K. Su, F. Jiang, J. Qian, J. Pang, S. A. Al-Thabaiti, S. M. Bawaked, M. Mokhtar, Q. Chen and M. Hong, Cryst. Growth Des., 2014, 14, 5865 CAS.
- K. Su, F. Jiang, J. Qian, K. Zhou, J. Pang, S. Basahel, M. Mokhtar, S. A. Al-Thabaiti and M. Hong, Inorg. Lett., 2014, 1, 1 Search PubMed.
- I. D. Brown and D. Altermatt, Acta Crystallogr., Sect. B: Struct. Sci., 1991, 47, 192 CrossRef . BVS of Mn ions for 1: Mn1, 1.99; Mn2, 2.37; Mn3, 2.05; Mn4, 2.15; Mn5, 2.08; Mn6, 2.19; Mn7, 2.13; Mn8, 2.19; Mn9, 2.01; Mn10, 2.18; Mn11, 2.00; Mn12, 2.29; Mn13, 1.97; Mn14, 1.83. BVS. of Mn ions for 2: Mn1, 2.11; Mn2, 2.10; Mn3, 2.08; Mn4, 2.14; Mn5, 2.15; Mn6, 2.17; Mn7, 2.05; Mn8, 1.98; Mn9, 1.98.
-
(a) M. Lamouchi, E. Jeanneau, A. Pillonnet, A. Brioude, M. Martini, O. Stephan, F. Meganem, G. Novitchi, D. Luneau and C. Desroches, Dalton Trans., 2012, 41, 2707 RSC . CCDC number for reference 19a are 835636 and 824786;
(b) T. Kajiwara, T. Kobashi, R. Shinagawa, T. Ito, S. Takaishi, M. Yamashita and N. Iki, Eur. J. Inorg. Chem., 2006, 1765 CrossRef CAS . CCDC number for reference 19b is 249858.
- N. Morohashi, N. Iki, A. Sugawara and S. Miyano, Tetrahedron, 2001, 57, 5557 CrossRef CAS.
- CrystalClear Version 1.3.6, Rigaku/MSC, The Woodlands, TX, 2004 Search PubMed.
-
(a) G. M. Sheldrick, SHELXS 97: Program for Crystal Structure Solution, University of Göttingen, Göttingen, Germany, 1997 Search PubMed;
(b) G. M. Sheldrick, SHELXS 97: Program for Crystal Structure Solution, University of Göttingen, Göttingen, Germany, 1997 Search PubMed.
- P. Vandersluis and A. L. Spek, Acta Crystallogr., Sect. A: Found. Crystallogr., 1990, 46, 194 CrossRef.
- R. A. Coxall, S. G. Harris, D. K. Henderson, S. Parsons, P. A. Tasker and R. E. Winpenny, J. Chem. Soc., Dalton Trans., 2000, 2349 RSC.
- A. R. Cowley and A. M. Chippindale, J. Chem. Soc., Dalton Trans., 2000, 3425 RSC.
-
(a) Y. Ma, N. A. G. Bandeira, V. Robert and E.-Q. Gao, Chem.–Eur. J., 2011, 17, 1988 CrossRef CAS PubMed;
(b) Y. Q. Wang, Q. Yue, Y. Qi, K. Wang, Q. Sun and E. Q. Gao, Inorg. Chem., 2013, 52, 4259 CrossRef CAS PubMed.
Footnote |
† Electronic supplementary information (ESI) available: Crystallographic data in CIF format, field dependence of magnetization (M) versus field (H) data, the M–H plots, TGA analyses and PXRD patterns for complexes 1 and 2. CCDC 1046923 and 1046924. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5ra02530c |
|
This journal is © The Royal Society of Chemistry 2015 |
Click here to see how this site uses Cookies. View our privacy policy here.